Quick Listen: Scrip’s Five Must-Know Things
Join us for an audio catch-up on the latest major developments in the global biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.
This episode includes major insights from around the biopharma world for the business week ended 8 January 2021.
This week, we take a look at a high-profile corporate logo change, further coronavirus vaccine developments, major drug launches last year despite the pandemic, and what one Japanese firm has been doing to cope with the new normal.
These podcasts are available on the Pharma Intelligence channel on Apple Podcasts, Google Play, SoundCloud and TuneIn and via smart speakers if one of these channels has been set up as your default podcast provider.
Stories mentioned in this episode:
(Also see "Pfizer Bids Farewell To Blue Pill With New Double Helix Logo" - Scrip, 6 Jan, 2021.)
(Also see "UK Authorizes ‘Gamechanger’ AstraZeneca Vaccine Despite Data Doubts" - Scrip, 30 Dec, 2020.)
(Also see "First In World COVID-19 Vaccine For Kids Below 12?" - Scrip, 6 Jan, 2021.)
(Also see "2020 Drug Launches, Like Everything, Will Be Remembered For COVID-19" - Scrip, 2 Jan, 2021.)
(Also see "Beyond The Pandemic, An Interview With Astellas’ Percival Barretto-Ko" - Scrip, 4 Jan, 2021.)